DJIA 16,643.01 -11.76 -0.07%
NASDAQ 4,828.33 15.62 0.32%
S&P 500 1,988.87 1.21 0.06%
market minute promo

11.42 0.21 (1.87%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BCRX $11.42 1.87%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $11.10
Previous Close $11.21
Daily Range $11.03 - $11.43
52-Week Range $7.85 - $16.83
Market Cap $836.4M
P/E Ratio -26.69
Dividend (Yield) $0.00 (0.0%)
Volume 424,931
Average Daily Volume 968,774
Current FY EPS -$0.60

Sector

Healthcare

Industry

Drug Makers

BioCryst Pharmaceuticals, Inc. (BCRX) Description

A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections. Website: http://www.biocryst.com/

News & Commentary

Why BioCryst Pharmaceuticals Was Sent to the Guillotine

BioCryst Pharmaceuticals crushes Wall Street's second-quarter expectations, but gets hammered anyway. Find out why.

Market Has Not Yet Noticed Potential in BioCryst Pharmaceuticals (BCRX); Have You?

New Strong Buy Stocks for August 11th

Esperion Therapeutics (ESPR) Looks Good: Stock Up 16.3%

Premarket Biotech Digest: SeekingAlpha Biotech Idea, Gilead Sales Updates, Sanofi Diabetes Collabora

Premarket Biotech Digest: SeekingAlpha Biotech Idea, Gilead Sales Updates, Sanofi Diabetes Collaboration

2 Biotech Stocks That Could Skyrocket In The Next 12 Months

3 Stocks Pushing The Health Care Sector Lower

BioCryst Pharmaceuticals' (BCRX) CEO Jon Stonehouse on Q2 2015 Results - Earnings Call Transcript

Friday's ETF Movers: GDX, XBI

Friday Sector Laggards: Cigarettes & Tobacco, Biotechnology Stocks

See More BCRX News...

BCRX's Top Competitors

BCRX $11.42 (1.87%)
Current stock: BCRX
AMGN $155.89 (0.11%)
Current stock: AMGN
GILD $107.78 (-0.19%)
Current stock: GILD
BIIB $303.69 (-0.26%)
Current stock: BIIB